Structural insights into the multiple functions of protein C inhibitor

Cellular and Molecular Life Sciences

Volumn 66, Issue 1, 2009, Pages 113-121

  Huntington, J A ^a   Li, W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cofactor; Haemostasis; Heparin; Phospholipid; Serpin; Structure; Thrombin

Indexed keywords

HEPARIN COFACTOR; PHOSPHOLIPID; PLASMINOGEN ACTIVATOR INHIBITOR 3; RETINOL ACETATE; SERINE PROTEINASE INHIBITOR; THROMBIN;

BAY REGION BINDING SITE; BINDING SITE; COMPLEX FORMATION; CRYSTALLOGRAPHY; FUNCTIONAL PROTEOMICS; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; PROTEINASE INHIBITION; REVIEW; STRUCTURAL PROTEOMICS;

BINDING SITES; HEPARIN; MODELS, MOLECULAR; PHOSPHOLIPIDS; PROTEIN C INHIBITOR; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; THROMBIN; TRETINOIN;

EID: 58149485443     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8371-0     Document Type: Review

References (43)

1. Geiger, M. (2007) Protein C inhibitor, a serpin with functions in- and outside vascular biology. Thromb. Haemost. 97, 343-347.
2. Marlar, R. A. and Griffin, J. H. (1980) Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J. Clin. Invest. 66, 1186-1189.
3. Suzuki, K., Nishioka, J. and Hashimoto, S. (1983) Protein C inhibitor. Purification from human plasma and characterization. J. Biol. Chem. 258, 163-168.
4. Segers, K., Dahlback, B. and Nicolaes, G. A. (2007) Coagulation factor V and thrombophilia: Background and mechanisms. Thromb. Haemost. 98, 530-542.
5. Dahlback, B. (1908) Early days of APC resistance and FV Leiden. Hamostaseologie 28, 103-109.
6. Rezaie, A. R., Cooper, S. T., Church, F. C. and Esmon, C. T. (1995) Protein C inhibitor is a potent inhibitor of the thrombin- thrombomodulin complex. J. Biol. Chem. 270, 25336-25339.
7. Nishioka, J., Ning, M., Hayashi, T. and Suzuki, K. (1998) Protein C inhibitor secreted from activated platelets efficiently inhibits activated protein C on phosphatidylethanolamine of platelet membrane and microvesicles. J. Biol. Chem. 273, 11281-11287.
8. Prendes, M. J., Bielek, E., Zechmeister-Machhart, M., Vanyek-Zavadil, E., Carroll, V. A., Breuss, J., Binder, B. R. and Geiger, M. (1999) Synthesis and ultrastructural localization of protein C inhibitor in human platelets and megakaryocytes. Blood 94, 1300-1312.
9. Rau, J. C., Beaulieu, L. M., Huntington, J. A. and Church, F. C. (2007) Serpins in thrombosis, hemostasis and fibrinolysis. J. Thromb. Haemost. 5 Suppl. 1, 102-115.
10. DiCera, E. (2008) Thrombin. Mol. Aspects Med. 29, 203-254.
11. Gettins, P. G. (2002) Serpin structure, mechanism, and function. Chem. Rev. 102, 4751-4804.
12. Silverman, G. A., Bird, P., I, Carrell, R. W., Church, F. C., Coughlin, P. B., Gettins, P. G. W., Irving, J. A., Lomas, D. A., Luke, C. J., Moyer, R. W., Pemberton, P. A., Remold-O'Donnell, E., Salvesen, G. S., Travis, J. and Whisstock, J. C. (2001) The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276, 33293-33296.
13. Huntington, J. A., Read, R. J. and Carrell, R. W. (2000) Structure of a serpin-protease complex shows inhibition by deformation. Nature 407, 923-926.
14. Schechter, I. and Berger, A. (1967) On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
15. Owen, M. C., Brennan, S. O., Lewis, J. H. and Carrell, R. W. (1983) Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N. Engl. J. Med. 309, 694-698.
16. Pratt, C. W. and Church, F. C. (1992) Heparin binding to protein C inhibitor. J. Biol. Chem. 267, 8789-8794.
17. Johnson, D. J., Li, W., Adams, T. E. and Huntington, J. A. (2006) Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation. EMBO J. 25, 2029-2037.
18. Li, W., Johnson, D. J., Esmon, C. T. and Huntington, J. A. (2004) Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat. Struct. Mol. Biol. 11, 857-862.
19. Baglin, T. P., Carrell, R. W., Church, F. C., Esmon, C. T. and Huntington, J. A. (2002) Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proc. Natl. Acad. Sci. USA 99, 11079-11084.
20. Li, W., Adams, T. E., Kjellberg, M., Stenflo, J. and Huntington, J. A. (2007) Structure of native protein C inhibitor provides insight into its multiple functions. J. Biol. Chem. 282, 13759-13768.
21. Huntington, J. A., Kjellberg, M. and Stenflo, J. (2003) Crystal structure of protein C inhibitor provides insights into hormone binding and heparin activation. Structure (Camb) 11, 205-215.
22. Huntington, J. A. (2006) Shape-shifting serpins - Advantages of a mobile mechanism. Trends Biochem. Sci. 31, 427-435.
23. Huntington, J. A. (2003) Mechanisms of glycosaminoglycan activation of the serpins in hemostasis. J. Thromb. Haemost. 1, 1535-1549.
24. Neese, L. L., Wolfe, C. A. and Church, F. C. (1998) Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor. Arch. Biochem. Biophys. 355, 101-108.
25. Jin, L., Abrahams, J. P., Skinner, R., Petitou, M., Pike, R. N. and Carrell, R. W. (1997) The anticoagulant activation of antithrombin by heparin. Proc. Natl. Acad. Sci. USA 94, 14683-14688.
26. Kuhn, L. A., Griffin, J. H., Fisher, C. L., Greengard, J. S., Bouma, B. N., Espana, F. and Tainer, J. A. (1990) Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor. Proc. Natl. Acad. Sci. USA 87, 8506-8510.
27. Elisen, M. G., Maseland, M. H., Church, F. C., Bouma, B. N. and Meijers, J. C. (1996) Role of the A+ helix in heparin binding to protein C inhibitor. Thromb. Haemost. 75, 760-766.
28. Espana, F., Berrettini, M. and Griffin, J. H. (1989) Purification and characterization of plasma protein C inhibitor. Thromb. Res. 55, 369-384.
29. Aznar, J., Espana, F., Estelles, A. and Royo, M. (1996) Heparin stimulation of the inhibition of activated protein C and other enzymes by human protein C inhibitor - Influence of the molecular weight of heparin and ionic strength. Thromb. Haemost. 76, 983-988.
30. Friedrich, U., Blom, A. M., Dahlback, B. and Villoutreix, B. O. (2001) Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C. J. Biol. Chem. 276, 24122-24128.
31. Yang, L., Manithody, C. and Rezaie, A. R. (2002) Contribution of basic residues of the 70-80-loop to heparin binding and anticoagulant function of activated protein C. Biochemistry 41, 6149-6157.
32. Ecke, S., Geiger, M., Resch, I., Jerabek, I., Sting, L., Maier, M. and Binder, B. R. (1992) Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein. J. Biol. Chem. 267, 7048-7052.
33. Li, W., Adams, T. E., Nangalia, J., Esmon, C. T. and Huntington, J. A. (2008) Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex. Proc. Natl. Acad. Sci. USA 105, 4661-4666.
34. Carter, W. J., Cama, E. and Huntington, J. A. (2004) Crystal structure of thrombin bound to heparin. J. Biol. Chem. 280, 2745-2749.
35. Fuentes-Prior, P., Iwanaga, Y., Huber, R., Pagila, R., Rumennik, G., Seto, M., Morser, J., Light, D. R. and Bode, W. (2000) Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature 404, 518-525.
36. Jerabek, I., Zechmeister-Machhart, M., Binder, B. R. and Geiger, M. (2001) Binding of retinoic acid by the inhibitory serpin protein C inhibitor. Eur. J. Biochem. 268, 5989-5996.
37. Pemberton, P. A., Stein, P. E., Pepys, M. B., Potter, J. M. and Carrell, R. W. (1988) Hormone binding globulins undergo serpin conformational change in inflammation. Nature 336, 257-258.
38. Zhou, A., Wei, Z., Read, R. J. and Carrell, R. W. (2006) Structuralmechanism for the carriage and release of thyroxine in the blood. Proc. Natl. Acad. Sci. USA 103, 13321-13326.
39. Klieber, M. A., Underhill, C., Hammond, G. L. and Muller, Y. A. (2007) Corticosteroid-binding globulin, a structural basis for steroid transport and proteinase-triggered release. J. Biol. Chem. 282, 29594-29603.
40. Zhou, A., Wei, Z., Stanley, P. L., Read, R. J., Stein, P. E. and Carrell, R. W. (2008) The S-to-R transition of corticosteroid-binding globulin and the mechanism of hormone release. J. Mol. Biol. 380, 244-251.
41. Malleier, J. M., Oskolkova, O., Bochkov, V., Jerabek, I., Sokolikova, B., Perkmann, T., Breuss, J., Binder, B. R. and Geiger, M. (2007) Regulation of protein C inhibitor (PCI) activity by specific oxidized and negatively charged phospholipids. Blood 109, 4769-4776.
42. Engelmann, B., Schaipp, B., Dobner, P., Stoeckelhuber, M., Kogl, C., Siess, W. and Hermetter, A. (1998) Platelet agonists enhance the import of phosphatidylethanolamine into human platelets. J. Biol. Chem. 273, 27800-27808.
43. Baumgartner, P., Geiger, M., Zieseniss, S., Malleier, J., Huntington, J. A., Hochrainer, K., Bielek, E., Stoeckelhuber, M., Lauber, K., Scherfeld, D., Schwille, P., Waldele, K., Beyer, K. and Engelmann, B. (2007) Phosphatidylethanolamine critically supports internalization of cell-penetrating protein C inhibitor. J. Cell. Biol. 179, 793-804.